Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

IMMUTEP LIMITED Director's Dealing 2025

Dec 4, 2025

65122_rns_2025-12-04_b29e180f-82c4-427e-93f5-9b70a1b7c676.pdf

Director's Dealing

Open in viewer

Opens in your device viewer

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity IMMUTEP LIMITED (ASX:IMM)
ABN 90 009 237 889

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director Mr Pete Meyers
Date of last notice 8 October 2025

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest Direct
Nature of indirect interest(including registered holder)Note: Provide details of the circumstances giving rise to therelevant interest. N/A
Date of change 1 December 2025
No. of securities held prior to change •4,052,173 Ordinary Fully Paid Shares•388,889 Performance Rights in accordancewith shareholder approval obtained at theAnnual General Meeting on 23 November2022.
Class Performance Rights
Number acquired 2,058,631 Performance Rights (ASX: IMMAM)
Number disposed N/A
  • See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

Value/ConsiderationNote: If consideration is non-cash, provide details andestimated valuation NilThe Performance Rights were issued asremuneration for services as a director as MrMeyers is taking his fees in PerformanceRights in lieu of cash and in accordancewith the shareholder approval obtained atthe Annual General Meeting held on 27November 2025.
No. of securities held after change •4,052,173 Ordinary Fully Paid Shares•388,889 Performance Rights in accordancewith shareholder approval obtained at theAnnual General Meeting on 23 November2022.•2,058,631PerformanceRightsinaccordance with shareholder approvalobtained at the Annual General Meeting on27 November 2025.
Nature of changeExample: on-market trade, off-market trade, exercise of options,issueofsecuritiesunderdividendreinvestmentplan,participation in buy-back 2,058,631 Performance Rights were acquired inaccordance with shareholder approval obtainedat the Annual General Meeting on 27 November2025.

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract N/A
Nature of interest
Name of registered holder(if issued securities)
Date of change
No. and class of securities to whichinterest related prior to changeNote: Details are only required for a contract inrelation to which the interest has changed
Interest acquired
Interest disposed
Value/ConsiderationNote: If consideration is non-cash, provide detailsand an estimated valuation
  • See chapter 19 for defined terms.

Appendix 3Y Page 2

01/01/2011

Appendix 3Y Change of Director’s Interest Notice

Interest after change

Part 3 –[+] Closed period

Part 3 –+Closed period
Were the interests in the securities or contracts detailedabove traded during a+closed period where prior writtenclearance was required? No
If so, was prior written clearance provided to allow the tradeto proceed during this period? N/A
If prior written clearance was provided, on what date was thisprovided? N/A
  • See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 3